Cited by 15Mobile Health and mHealth ApplicationsDiabetes Management and ResearchDiabetes Management and Education

The role of smartwatch technology in the provision of care for type 1 or 2 diabetes mellitus or gestational diabetes: systematic review

Open access
Diez Alvarez, Sergio, Fellas, Antoni, Wynne, Katie, Santos, Derek, Sculley, Dean, Acharya, Shamasunder, Navathe, Pooshan, Gironès, Xavier +1 more·2024·JMIR mhealth and uhealth

Abstract

Background: The use of smart technology in the management of all forms of diabetes mellitus has grown significantly in the past 10 years. Technologies such as the smartwatch have been proposed as a method of assisting in the monitoring of blood glucose levels as well as other alert prompts such as medication adherence and daily physical activity targets. These important outcomes reach across all forms of diabetes and have the potential to increase compliance of self-monitoring with the aim of improving long-term outcomes such as hemoglobin A1c (HbA1c). Objective: This systematic review aims to explore the literature for evidence of smartwatch technology in type 1, 2, and gestational diabetes. Methods: A systematic review was undertaken by searching Ovid MEDLINE and CINAHL databases. A second search using all identified keywords and index terms was performed on Ovid MEDLINE (January 1966 to August 2023), Embase (January 1980 to August 2023), Cochrane Central Register of Controlled Trials (CENTRAL, the Cochrane Library, latest issue), CINAHL (from 1982), IEEE Xplore, ACM Digital Libraries, and Web of Science databases. Type 1, type 2, and gestational diabetes were eligible for inclusion. Quantitative studies such as prospective cohort or randomized clinical trials that explored the feasibility, usability, or effect of smartwatch technology in people with diabetes were eligible. Outcomes of interest were changes in blood glucose or HbA1c, physical activity levels, medication adherence, and feasibility or usability scores. Results: Of the 8558 titles and abstracts screened, 5 studies were included for qualitative synthesis in this review. A total of 322 participants with either type 1 or type 2 diabetes mellitus were included in the review. A total of 4 studies focused on the feasibility and usability of smartwatch technology in diabetes management. One study conducted a proof-of-concept randomized clinical trial including smartwatch technology for exercise time prescriptions for participants with type 2 diabetes mellitus. Adherence of participants to smartwatch technology varied between included studies, with one reporting input submissions of 58% and another reporting that participants logged 50% more entries than they were required to. One study reported significantly improved glycemic control with integrated smartwatch technology, with increased exercise prescriptions; however, this study was not powered and required a longer observational period. Conclusions: This systematic review has highlighted the lack of robust randomized clinical trials that explore the efficacy of smartwatch technology in the management of patients with type 1, type 2, and gestational diabetes. Further research is required to establish the role of integrated smartwatch technology in important outcomes such as glycemic control, exercise participation, drug adherence, and diet monitoring in people with all forms of diabetes mellitus.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2196/54826

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [16]16. Hirst JE, Mackillop L, Loerup L, Gibson OJ, Farmer AJ, Bartlett K, et al. GDm-Health: a pilot study examining acceptability of mobile phone assisted remote blood glucose monitoring for women with gestational diabetes mellitus. Reprod Sci. 2014;21(3):252A–253A.
  2. [31]31. Al-Hajri M, Al-Kawari S, Al-Kharusi A, et al. Why mobile apps for type II diabetes fail to actualize behavioral change among adolescents? Diabetes Technol Ther. 2020;22:A235

Cited by

Sorted by citations

Authors
Diez Alvarez, S., Fellas, A., Wynne, K., Santos, D., Sculley, D., Acharya, S., Navathe, P., Gironès, X., & Coda, A.
Affiliations
  • Hunter Medical Research Institute (AU)
  • John Hunter Hospital (AU)
  • Queen Margaret University (GB)
  • University of Newcastle Australia (AU)
  • Central Queensland Hospital and Health Service (AU)
  • Generalitat de Catalunya (ES)
Venue
JMIR mhealth and uhealth
Published
2024-12-03
Volume
12
Pages
e54826-e54826
ISSN
2291-5222 (ISSN-L)
OpenAlex
W4401872659
Cited by
15
References
45
Citations by year
2026: 8 · 2025: 7
FWCI
1.36
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • JMIR mhealth and uhealth (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Queen Margaret University Publications Repository (Queen Margaret University) (submittedVersion, cc-by)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
smartwatches, diabetes mellitus, type 1 diabetes, type 2 diabetes, gestational diabetes mellitus, blood glucose monitoring, glycemic control, HbA1c, medication adherence, physical activity, exercise prescription, feasibility and usability, self-monitoring, wearable devices, diabetes management, user engagement, technology adoption barriers, cost barriers, digital health interventions
MeSH terms
Wearable Electronic Devices, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Humans, Pregnancy, Blood Glucose Self-Monitoring, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review